Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in Select Medical Holdings Co. (NYSE:SEM – Get Rating) by 13.6% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 14,417 shares of the health services provider's stock after buying an additional 1,722 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank's holdings in Select Medical were worth $319,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds have also modified their holdings of SEM. Bank of New York Mellon Corp raised its position in shares of Select Medical by 0.8% in the first quarter. Bank of New York Mellon Corp now owns 1,478,832 shares of the health services provider's stock valued at $35,478,000 after buying an additional 11,231 shares during the last quarter. MetLife Investment Management LLC grew its holdings in shares of Select Medical by 46.7% in the first quarter. MetLife Investment Management LLC now owns 59,542 shares of the health services provider's stock valued at $1,428,000 after purchasing an additional 18,949 shares during the period. Rhumbline Advisers grew its holdings in shares of Select Medical by 6.7% in the first quarter. Rhumbline Advisers now owns 284,568 shares of the health services provider's stock valued at $6,827,000 after purchasing an additional 17,762 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its stake in Select Medical by 14.1% during the first quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 91,360 shares of the health services provider's stock worth $2,192,000 after buying an additional 11,264 shares during the period. Finally, BlackRock Inc. boosted its stake in Select Medical by 4.3% during the first quarter. BlackRock Inc. now owns 18,575,139 shares of the health services provider's stock worth $445,617,000 after buying an additional 762,219 shares during the period. 78.75% of the stock is currently owned by institutional investors and hedge funds.
Get
Select Medical
alerts:
Analyst Upgrades and Downgrades
Several brokerages have recently issued reports on SEM. Royal Bank of Canada reduced their price target on shares of Select Medical from $36.00 to $32.00 and set an "outperform" rating on the stock in a research report on Monday, November 7th. TheStreet lowered shares of Select Medical from a "b" rating to a "c+" rating in a research report on Wednesday, November 16th. Deutsche Bank Aktiengesellschaft lowered their price objective on shares of Select Medical from $44.00 to $35.00 in a research report on Monday, November 7th. Finally, Credit Suisse Group set a $24.00 target price on shares of Select Medical in a research report on Thursday, November 24th.
Select Medical Trading Up 0.2 %
NYSE:SEM opened at $30.14 on Monday. The company has a market capitalization of $3.83 billion, a PE ratio of 21.84, a price-to-earnings-growth ratio of 0.94 and a beta of 1.38. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 2.81. Select Medical Holdings Co. has a 52-week low of $18.86 and a 52-week high of $30.63. The stock has a fifty day simple moving average of $27.12 and a 200-day simple moving average of $25.59.
Select Medical Profile
(Get Rating)
Select Medical Holdings Corp. engages in the provision of medical rehabilitation services. It operates through the following segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation and Concentra. The Critical Illness Recovery Hospital segment serves patients with debilitating injuries and rehabilitation needs that cannot be adequately cared in a medically intensive environment, such as a skilled nursing facility.
Featured Stories
- Get a free copy of the StockNews.com research report on Select Medical (SEM)
- MarketBeat Week in Review – 2/13 – 2/17
- Deere Stock Raises Outlook and is Ready to Power Higher
- DraftKings Crowning Achievement: Leverage
- Tesla Stock Comeback Is Picking Up Steam
- How Abbott Labs, AbbVie Could Profit on Seizure Drug Formula
Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.
VIP课程推荐
APP专享直播
热门推荐
收起24小时滚动播报最新的财经资讯和视频,更多粉丝福利扫描二维码关注(sinafinance)